NIH/NIMH Research News Update 11-22-09
The NIH/NIMH Research Update for 11-22-09 brings new information on a potentially groundbreaking drug to treat Fragile X Syndrome that enters a clinical trial phase, brain imaging (MRI) studies that track development of children’s brains, significant grant money to be allocated for Autism research, combined antidepressant and Cognitive Behavioral Therapy (CBT) is most effective treatment for depression in teens, children with Autism Spectrum Disorder who have serious behavioral problems respond best to treatments that include medication plus a structured training program for parents, and more.
Here is the NIH/NIMH Research News Update for 11-22-09:
- Parent Training Complements Medication for Treating Behavioral Problems in Children with Pervasive Developmental Disorders
- Long-term Depression Treatment Leads to Sustained Recovery for Most Teens
- NIH Encourages Depressed Moms to Seek Treatment for Themselves
- Recovery Act Grant Aims to Teach Kids with Autism How to Better Express Themselves
- NIMH Seeks More BRAINS
- NIH Awards More than 50 Grants to Boost Search for Causes, Improve Treatments for Autism
- Kids’ Brain Development Charted as They Grow Up
- Clinical Tests Begin on Medication to Correct Fragile X Defect
- Significant Weight Gain, Metabolic Changes Associated with Antipsychotic Use in Children
Enjoy.

A Clinical Outcome Study Of Neurofeedback And Biofeedback For Migraine Headache